https://digitalcommons.library.tmc.edu/uthgsbs_docs/1679/
"Preclinical Development of 1B7/CD3, a Novel Anti-Tslpr Bispecific Anti" by Ze Tian, Chunhua Shi et...
Patients harboring CRLF2-rearranged B-lineage acute lymphocytic leukemia (B-ALL) face a 5-year survival rate as low as 20%. While significant gains have been...
preclinical developmentnovelantitslprbispecific